TCL Archive FDA Asks Advisory Group To Define Role Of Single-Arm Studies In Four Applications September 4, 2009
TCL Archive A Message From NCI: “We Deeply Regret The Need To Eliminate This Program.” AP4 Applicants And Corporate Partners Spent Years, Money, Before NCI Pulled The Plug On Novel Public-Private Partnerships. Von Eschenbach Called AP4 “A New Paradigm” For Drug Development. NCI Executive Committee “Prioritized” Programs. April 21, 2006
TCL Archive In Brief: Fischinger Hints of “New Player” At FCRF; Gigliotti Named Cancer Control Science Director December 12, 1986
